Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$21.52 - $36.02 $31,311 - $52,409
-1,455 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$27.42 - $48.97 $274 - $489
10 Added 0.69%
1,455 $43,000
Q2 2021

Aug 12, 2021

BUY
$39.41 - $47.25 $2,955 - $3,543
75 Added 5.47%
1,445 $63,000
Q1 2021

May 13, 2021

BUY
$43.34 - $65.91 $4,117 - $6,261
95 Added 7.45%
1,370 $60,000
Q4 2020

Feb 12, 2021

BUY
$23.3 - $59.57 $18,709 - $47,834
803 Added 170.13%
1,275 $69,000
Q3 2020

Nov 13, 2020

BUY
$20.5 - $28.59 $9,676 - $13,494
472 New
472 $10,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $663M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.